Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
BeOne Medicines
Eli Lilly and Company
Gilead Sciences
H. Lee Moffitt Cancer Center and Research Institute
Universität des Saarlandes
Incyte Corporation
Celgene
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Janssen Research & Development, LLC
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
AstraZeneca
BeiGene
BeiGene
Stanford University
University of Rochester
City of Hope Medical Center
University of Colorado, Denver
Mayo Clinic
University of Nebraska
University of Nebraska
OHSU Knight Cancer Institute
Ipsen
TG Therapeutics, Inc.
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
Atara Biotherapeutics
Brown University
Mayo Clinic
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Barbara Ann Karmanos Cancer Institute
Gilead Sciences
Novartis
Masonic Cancer Center, University of Minnesota
Mayo Clinic
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
National Cancer Institute (NCI)
Mayo Clinic
Fred Hutchinson Cancer Center
University of Arizona
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute